Pulse Biosciences (PLSE) Net Cash Flow Growth (3y) (2018 - 2025)
Pulse Biosciences (PLSE) Net Cash Flow Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 39.87% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -16.59% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -55.30% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.16% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 78.59% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -159.90% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 36.49% |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - | -21.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.75% |
| Sep 30, 2025 | -30.15% |
| Jun 30, 2025 | -100.77% |
| Mar 31, 2025 | 27.61% |
| Dec 31, 2024 | 70.03% |
| Sep 30, 2024 | 127.16% |
| Jun 30, 2024 | 11.31% |
| Mar 31, 2024 | -30.06% |
| Dec 31, 2023 | -46.07% |
| Sep 30, 2023 | 35.18% |
| Jun 30, 2023 | -46.23% |
| Mar 31, 2023 | -110.27% |
| Dec 31, 2022 | -44.28% |
| Sep 30, 2022 | 260.70% |
| Jun 30, 2022 | -1.85% |
| Mar 31, 2022 | 27.92% |
| Dec 31, 2021 | -31.98% |
| Sep 30, 2021 | -127.27% |
| Jun 30, 2021 | -47.61% |
| Mar 31, 2021 | 86.75% |